With CMS’s New List of Meds for Drug Price Negotiation, Analyst Sees Small Financial Hit to Pharmas
Whereas the 15 drugs chosen for the most recent spherical of the federal authorities’s drug value negotiation program will face ...
Whereas the 15 drugs chosen for the most recent spherical of the federal authorities’s drug value negotiation program will face ...
OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the ...
AbbVie is diversifying its oncology pipeline, paying $650 million for a clinical-stage drug that goes after two targets to fight ...
SAN FRANCISCO — On Sunday, Alnylam, the gene-silencing company that notched one gigantic accomplishment after another over the past five years, ...
Eli Lilly is building its prospects in immunology through the $1.2 billion acquisition of Ventyx Biosciences, a clinical-stage company with ...
In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, ...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign ...
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
More than three dozen state attorneys general are urging Meta to better enforce its policies to thwart a “surge of ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.